Clinical Study of Limosilactobacillus reuteri for the Treatment of Children with Chronic Tic Disorders/Tourette Syndrome: A Mid-Term Efficacy Evaluation
Abstract Introduction Gut microbiota plays an important role in tic disorders (TDs); however, clinical research on probiotics for chronic TDs treatment is lacking. We aimed to investigate the effectiveness of probiotics, hypothesizing that their clinical efficacy is comparable to that of clonidine i...
Saved in:
Main Authors: | Yan Liang, Lin Wan, Guanglei Wang, Huimin Yan, Jing Zhang, Xinting Liu, Ziyan Zhang, Gang Zhu, Guang Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2024-12-01
|
Series: | Neurology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40120-024-00693-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Limosilactobacillus reuteri - a probiotic gut commensal with contextual impact on immunity
by: Amanda H. Lee, et al.
Published: (2025-12-01) -
Biological Characteristics Analysis of Limosilactobacillus reuteri JBR3 and the Effect of Protective Agents on Its Viability
by: Jun HAN, et al.
Published: (2025-02-01) -
Exopolysaccharides from camel milk-derived Limosilactobacillus reuteri C66: Structural characterization, bioactive and rheological properties for food applications
by: A.K.M. Humayun Kober, et al.
Published: (2025-01-01) -
Real-world of Limosilactobacillus reuteri in mitigation of acute experimental colitis
by: Ningning Yue, et al.
Published: (2025-01-01) -
<i>Limosilactobacillus reuteri</i> ZY15 Alleviates Intestinal Inflammation and Barrier Dysfunction via AKT/mTOR/HIF-1α/RORγt/IL-17 Signaling and the Gut Microbiota in ETEC K88-Challenged <i>Mice</i>
by: Xin Xu, et al.
Published: (2025-01-01)